000 01599 a2200457 4500
005 20250513154414.0
264 0 _c19981207
008 199812s 0 0 eng d
022 _a0022-3565
040 _aNLM
_beng
_cNLM
100 1 _aGriswold, D E
245 0 0 _aSB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo.
_h[electronic resource]
260 _bThe Journal of pharmacology and experimental therapeutics
_cNov 1998
300 _a705-11 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a3',5'-Cyclic-AMP Phosphodiesterases
_xantagonists & inhibitors
650 0 4 _aAdoptive Transfer
650 0 4 _aAnimals
650 0 4 _aCyclic Nucleotide Phosphodiesterases, Type 4
650 0 4 _aCyclohexanecarboxylic Acids
_xpharmacology
650 0 4 _aHumans
650 0 4 _aInterleukin-4
_xantagonists & inhibitors
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred Strains
650 0 4 _aMonocytes
650 0 4 _aNitriles
650 0 4 _aPhosphodiesterase Inhibitors
_xpharmacology
650 0 4 _aPyrrolidinones
_xpharmacology
650 0 4 _aRolipram
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
700 1 _aWebb, E F
700 1 _aBadger, A M
700 1 _aGorycki, P D
700 1 _aLevandoski, P A
700 1 _aBarnette, M A
700 1 _aGrous, M
700 1 _aChristensen, S
700 1 _aTorphy, T J
773 0 _tThe Journal of pharmacology and experimental therapeutics
_gvol. 287
_gno. 2
_gp. 705-11
999 _c9773048
_d9773048